Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125266451 | 12526645 | 1 | I | 20160623 | 20160705 | 20160705 | EXP | JP-LUPIN PHARMACEUTICALS INC.-2016-02905 | LUPIN | YOUSUKE S, SHINICHIROU N, TAKECHI, KAZUHITO S, TAKUYA W, HIROMI T, GYOUKEI T, AKIKI T. IMPAIRED CONSCIOUSNESS DUE TO OXATOMIDE IS QUESTIONED IN ONE CASE. FIRST JAPAN CLINICAL PHARMACOLOGY SOCIETY, TOKAI, HOKURIKU DISTRICT MEETING. 2016 MAY 28;17:. | 82.00 | YR | M | Y | 0.00000 | 20160705 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125266451 | 12526645 | 1 | SS | Oxatomide | OXATOMIDE | 1 | Oral | UNKNOWN | 0 | ||||||||||
| 125266451 | 12526645 | 2 | SS | VALACYCLOVIR | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | UNKNOWN | 0 | ||||||||||
| 125266451 | 12526645 | 3 | PS | Diclofenac | DICLOFENAC | 1 | Oral | UNKNOWN | 204132 | ||||||||||
| 125266451 | 12526645 | 4 | SS | Diclofenac | DICLOFENAC | 1 | Oral | UNKNOWN | 205878 | ||||||||||
| 125266451 | 12526645 | 5 | SS | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | Oral | UNKNOWN | 0 | ||||||||||
| 125266451 | 12526645 | 6 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | UNKNOWN | 0 | ||||||||||
| 125266451 | 12526645 | 7 | SS | Rabeprazole | RABEPRAZOLE | 1 | Oral | UNKNOWN | 78964 | ||||||||||
| 125266451 | 12526645 | 8 | SS | SALBACTUM | SULBACTAM | 1 | Intravenous (not otherwise specified) | UNKNOWN | 0 | ||||||||||
| 125266451 | 12526645 | 9 | SS | Ampicillin | AMPICILLIN | 1 | Intravenous (not otherwise specified) | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125266451 | 12526645 | 1 | Pneumonia |
| 125266451 | 12526645 | 2 | Pneumonia |
| 125266451 | 12526645 | 3 | Pneumonia |
| 125266451 | 12526645 | 4 | Pneumonia |
| 125266451 | 12526645 | 5 | Pneumonia |
| 125266451 | 12526645 | 6 | Pneumonia |
| 125266451 | 12526645 | 7 | Pneumonia |
| 125266451 | 12526645 | 8 | Pneumonia |
| 125266451 | 12526645 | 9 | Pneumonia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125266451 | 12526645 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125266451 | 12526645 | Altered state of consciousness | |
| 125266451 | 12526645 | Drug interaction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |